News Roche breast cancer trial success could kill Puma's rival Perjeta trial success sends rival biotech's share price crashing.
News Patient death raises concerns over Roche haemophilia drug Concerns following event on HAVEN1 trial.
News Novartis' Zykadia gets fast first-line lung cancer review Roche rival has Breakthrough Therapy status.
News Truxima, world's first cancer drug biosimilar approved in Eu... Roche's top seller faces rival four years after patent expiry
News mySugr impresses, expands Roche partnership Data indicates a 20% drop in average blood glucose levels over six months.
News Opdivo still clear immunotherapy leader despite Keytruda gai... Immunotherapy takes on rivals from Roche and BMS.
News Australia starts probe into AI infiltration of Medicare The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
